Sign In  |  Register  |  About Santa Clara  |  Contact Us

Santa Clara, CA
September 01, 2020 1:39pm
7-Day Forecast | Traffic

  • Search Hotels in Santa Clara

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Novartis' STAMP Inhibitor Under FDA Review For Myeloid Leukemia
Tickers NVS
Tags Biotech Benzinga Health Care
From Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Tickers ABBV AGEN ALKS AVTE
Tags AXNX IBB TLSA
From Benzinga
Novartis's Kymriah Flunks In Late-Stage NHL Study
Tickers NVS
Tags Briefs News Non Hodgkin Lymphoma
From Benzinga
Could Veeva Systems Stock Help You Retire a Millionaire?
Tickers CRM GSK MRK NVS
Tags VEEV Market News GSK
From Motley Fool
Novartis Shares Two Year Beovu Data From Diabetic Macular Edema Studies
Tickers NVS REGN
Tags Market News NVS General
From Benzinga
FDA to authorize booster vaccine dose for people with weak immune systems, and WHO to test 3 drugs as possible treatments for hospitalized COVID patients
Tickers BNTX JNJ MRNA NVS
Tags PFE IN:524494 MRNA
From MarketWatch
WHO-Led Study To Test Three Anti-Inflammatory Drugs For COVID-19
Tickers JNJ NVS
Tags Benzinga JNJ Health Care
From Benzinga
Understanding Novartis's Unusual Options Activity
Tickers NVS
Tags BZI/UOA NVS Movers
From Benzinga
Here Are the Winners of Cowen's Big Pharma R&D Showdown
Tickers ABBV COWN LLY MRK
Tags RHHBY MRK COWN
From Motley Fool
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Tickers ABSI ACET ADCT ADVM
Tags WST MRNS MCRB
From Benzinga
Tilray Stock Makes Profit, Crowd Goes Wild!
Tickers BUD NVS TLRY
Tags NVS Market News TLRY
From InvestorPlace
Cannabis Movers & Shakers: BioHarvest Sciences, Green Hygienics, Realm of Caring, Media Central Corp, Al Harrington's Viola
Tickers GRYN GSK NVS PFE
Tags General Movers & Shakers Realm of Caring
From Benzinga
Rani Therapeutics Debuts On The Nasdaq: What You Should Know About The Biopharma
Tickers IPOS NVS RANI
Tags IPOs General Biotech
From Benzinga
Why XOMA Stock Is Trading Higher Wednesday?
Tickers AG NVS XOMA
Tags Biotech Benzinga Briefs
From Benzinga
Novartis' TGFβ Targeted Antibody Secures FDA Orphan Drug Tag For Pancreatic Cancer
Tickers NVS
Tags NVS Market News General
From Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
Tickers ABBV ACIU AGIO AGRX
Tags Biotech EVLO ANVS
From Benzinga
Novartis (NVS) Q2 2021 Earnings Call Transcript
Tickers NVS
Tags NVS Market News
From Motley Fool
15 European Dividend Aristocrats to Diversify Your Portfolio
Tickers ASHTY BTI CLPBY DEO
Tags KRYAY ASHTY Dividend Stocks
From InvestorPlace
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Tickers ABCL ADAP AFIB ALNY
Tags ADAP OMIC TECH
From Benzinga
Earnings Scheduled For July 21, 2021
Tickers ANTM CSX DFS HOG
Tags THC Earnings Scheduled Markets
From Benzinga
A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings
Tickers ANTM CMG ISRG JNJ
Tags VZ Market News KO
From Benzinga
Rebound from Monday’s rout continues with Dow futures up 200 points and European equities higher
Tickers ASML COMP NVS SAP
Tags XE:DAI DX:DAX SPX
From MarketWatch
Novartis Posts Q2 Earnings Beat As Sales Pick Up; Reiterates 2021 Guidance
Tickers NVS
Tags General Market News NVS
From Benzinga
2 Compelling Reasons to Buy This Reawakened Pharma Giant
Tickers AZN LLY NVS
Tags AZN Market News NVS
From Motley Fool
Can CRISPR Therapeutics Stock Investors Steer Clear of Ethical Concerns?
Tickers CRSP NVS
Tags CRSP Market News NVS
From InvestorPlace
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Tickers ABCL ACET ACHL ADVM
Tags ALVR FDMT CDTX
From Benzinga
Incyte's Ruxolitinib Shows Better Outcomes Regardless Of Organs Affected In GvHD Patients
Tickers INCY NVS
Tags Market News NVS GVHD
From Benzinga
Cowen Initiates Coverage On Molecular Partners With Price Target Of $50
Tickers MLLCF MOLN NVS
Tags Briefs Price Target Benzinga
From Benzinga
Celldex Stock Surges As It Touts Early-Stage Skin Disease Study Win For CDX-0159
Tickers CLDX NVS RHHBF RHHBY
Tags Biotech Benzinga Briefs
From Benzinga
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
Tickers BIIB NVS PFE QURE
Tags SAGE QURE NVS
From Motley Fool
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SantaClara.com & California Media Partners, LLC. All rights reserved.